BACKGROUND One of the most notable applications for circulating tumor DNA (ctDNA)
detection in peripheral blood of patients with metastatic colorectal cancer (mCRC) is a long-term …

Background/Aim: Circulating tumour DNA (ctDNA) represents an emerging biomarker in non-small
cell lung cancer (NSCLC). We focused on the combination of ctDNA and positron …

A leading pharmacological strategy toward HIV cure requires “shock” or activation of HIV
gene expression in latently infected cells with latency reversal agents (LRAs) followed by their …

Protein–protein interactions play a central role in the regulation of many biochemical processes
(eg the system participating in enzyme catalysis). Therefore, a deeper understanding of …

Background: Observation of anticancer therapy effect by monitoring of minimal residual
disease (MRD) is becoming an important tool in management of non-small cell lung cancer (…

Protein–protein interaction was investigated using a protein nanoprobe capable of photo-initiated
cross-linking in combination with high-resolution and tandem mass spectrometry. This …

Purpose: To investigate potential association between selected tumor markers and
laboratory parameters (lactate dehydrogenase [LDH], neutrophils, hemoglobin, neutrophils, …

OBJECTIVES: The mammalian mixed function oxidase (MFO) system participates in hydroxylation
of many hydrophobic endogenous compounds as well as xenobiotics such as drugs …

Simple Summary Identifying patients with an increased risk of early recurrence of colorectal
lesions is still a problem. In our study, we focused on improving this identification by …

Introduction: Liquid biopsy based on detection of circulating tumor DNA (circulating-tumor
DNA, ctDNA) is finding new applications in clinical management of solid cancers. From the …